Rosalie M. Luiten PhD
 Department of Dermatology and
The Netherlands Institute for Pigment Disorders
Academic Medical Center
University of Amsterdam
Meibergdreef 9, room L3-116
NL-1105 AZ Amsterdam
The Netherlands
Contact
Research experience: 2008 to present: Head of the Laboratory of Experimental Dermatology
2007 to present: AMC principal investigator (PI)
2005-present: Assistant professor at the Netherlands Institute for Pigment Disorders and department of Dermatology of the Academic Medical Center of the University of Amsterdam. Studying the pathogenesis of vitiligo and its application in immunotherapy of melanoma. Supervisor of two PhD students, one Postdoctoral fellow, two technicians and one MSc student. Awarded in 2005 a research grant of €460,000 from the Dutch Cancer Society to study the susceptibility of melanoma for autoimmune attack, an important prognostic factor for the potential success of immunotherapy in combating melanoma. 2003-2004
Senior Postdoctoral Research Fellow at the Department of Immunohematology and Blood Transfusion, Leiden University Medical Center, Leiden. Awarded a research grant (€ 110,000) from the Netherlands Institute of Pigment Disorders at the University of Amsterdam to start a new research line on the pathogenesis of vitiligo and its application in immunotherapy of melanoma.
In 2004, awarded the NWO-VIDI personal grant of € 600.000 from the Innovational Research Program of the Dutch Organization of Scientific Research (NWO). 1999-2003
Postdoctoral Research Fellow at the Department of Immunology, The Netherlands Cancer Institute / Antoni van Leeuwenhoek hospital, Amsterdam. Developed innovative immunotherapeutic strategies, including autologous tumor cell vaccines and immortalized human T lymphocytes, for the treatment of melanoma. Treatment evaluation performed both in experimental models and in melanoma patients in a Phase I clinical study.
1997-1999
Marie Curie Research Fellow at the Ludwig Institute for Cancer Research (LICR) in Brussels (dr. P. van der Bruggen, Prof. dr. T. Boon).
Marie Curie postdoctoral research fellow at the Christian de Duve Institute of Cellular Pathology, Cellular Genetics Unit, in Brussels. Awarded a personal fellowship (€ 150,000) to work two years in the group of dr. P. van der Bruggen and prof. dr. T. Boon. Developed cancer vaccines derived from MAGE genes. Invented five new cancer vaccines that are patented worldwide for clinical application.
Research grants: 2010 Dutch Cancer Society (KWF) Research grant in collaboration with prof. dr. H. Spits, Tytgat Institute AMC, University of Amsterdam
2010 AMC - SKE Preseed, I amstarter
2010 Life Science Center Amsterdam (LSCA) Validation Fund, Amsterdam Innovation Motor,
2008 KWF fellowship for medical interns granted to drs. H-E Teulings
2007 Dutch Cancer Society (KWF) Research grant in collaboration with dr. K.A. Reedquist, Dept of exp Immunology, AMC.
2006-present: WBSO funding associated with the grants from KWF and NWO-VIDI, principal investigator
2005 Dutch Cancer Society (KWF) Research grant
2004 NWO (Netherlands Organization of Scientific Research) -VIDI research fellowship
2003 The Netherlands Institute of Pigment Disorders (SNIP) research fellowship
1997 Marie Curie Individual Research fellowship from the European Commission (TMR).
1993 Research fellowship from Centocor Inc. (Malvern, PA)
Education:
PhD. at the University of Leiden.
Title of the thesis: "New chimeric monoclonal antibodies against human carcinoma. IgE and bispecific antibody-mediated therapy", (Prof. dr. S.O. Warnaar and Prof. dr. G.J. Fleuren); Prof. dr. L.J. Old, Ludwig Institute for Cancer Research, New York, USA (referee).
Doctorandus (MSc.) in Biomedical Sciences, University of Leiden.
French Language and Literature, University of Grenoble III, France, first and second degree.
. Ontwerp en realisatie: Nico van Dijk Media
 Top
| 